Does Dr. JESSICA ALDERETE have financial conflicts of interest?

Dr. JESSICA ALDERETE (CPNP-AC) has received a total of $121 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $121 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JESSICA ALDERETE?

According to CMS Open Payments data, Dr. JESSICA ALDERETE received funding from OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION ($108) and GLAXOSMITHKLINE ($12).

Does Dr. JESSICA ALDERETE receive research grants or speaking fees?

Dr. JESSICA ALDERETE has received $121 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JESSICA ALDERETE

CPNP-ACReal-Time Hydrated

Specialty: Nurse Practitioner, Pediatrics

Practice Location: ROSWELL, NM 88201

NPI Number: 1750907770

LIFETIME INDUSTRY VALUE

$121

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALDERETE is a verified Nurse Practitioner, Pediatrics practitioner based in ROSWELL, NM.

Between 2021 and 2025, Dr. ALDERETE had an overall industry promotional and research financial footprint of $121 as recorded in the federal CMS Open Payments database.

$121 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALDERETE's primary funding source is OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, which accounts for $108 (representing 89.7% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION

Rank 1

$108

89.7%

GLAXOSMITHKLINE

Rank 2

$12

10.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.